[Clinicopathological features of NTRK3 gene rearrangement papillary thyroid carcinoma].

Objective: To investigate the clinicopathological features and differential diagnosis of NTRK3 gene rearrangement thyroid papillary carcinoma (PTC). Methods: The PTC cases without BRAF V600E mutation were collected at Fujian Provincial Hospital South Branch from January 2015 to January 2020. The cases of NTRK3 gene rearrangement PTC were examined using immunohistochemistry and fluorescence in situ hybridization (FISH). The clinical data, histopathological characteristics, immunohistochemical features and molecular pathological changes were retrospectively analyzed. Data from the TCGA PTC dataset and the literature were also studied. Results: A total of 3 PTC cases harboring NTRK3 gene rearrangement were confirmed. All the patients were female, aged from 26,49,34 years. Histologically, two of them demonstrated a multinodular growth pattern. Only one case showed prominent follicular growth pattern; the other two tumors showed a mixture of follicular, papillary and solid growth patterns. All tumors showed a typical PTC nuclear manifestation, with some nuclear pleomorphism, vacuolated foci and oncocytic features. The characteristic formation of glomeruloid follicular foci was present in two cases which also showed psammoma bodies, and tumoral capsular or angiolymphatic invasion. The background thyroid parenchyma showed chronic lymphocytic thyroiditis. Mitotic rates were low, and no cases had any tumor necrosis. The pan-TRK and TTF1 testing was both positive in 3 cases, while S-100 and mammaglobin were both negative in them. FISH studies confirmed the NTRK3 gene rearrangement in all 3 cases. Studies on the TCGA datasets and literature revealed similar findings. Conclusions: NTRK3 gene rearrangement PTC is rare. It may be easily misdiagnosed due to the lack of histological and clinicopathological characteristics. Molecular studies such as pan-TRK immunostaining, FISH and even next-generation sequencing are needed to confirm the diagnosis. Immunohistochemistry of pan-TRK performed in the PTC cases without BRAF V600E mutation can be used as a good rapid-screening tool. With the emergence of pan-cancer tyrosine receptor kinase inhibitors, proper diagnosis of these tumors can help determine appropriate treatments and improve their outcomes.

Evaluation of Au/γ-Al2O3 nanocatalyst for plasma-catalytic decomposition of toluene.

The emission of toluene into the atmosphere can seriously affect the environmental quality and endanger human health. A dielectric barrier discharge reactor filled with a small amount of Au nanocatalysts was used to decompose toluene in He and O2 gases mixtures at room temperature and atmospheric pressure. Normally, the oxidation of toluene using Au nanocatalysts suffers from low reaction activity and facile catalyst deactivation. Herein, the effects of Au loading, calcination time and calcination temperature were systematically investigated. It was found that 0.1 wt%Au/γ-Al2O3 calcined at 300 °C for 5 h can keep an average size around 6 nm with good dispersion on γ-Al2O3 surface and display the best catalytic performance. Moreover, the influences of energy density, gas flow rate, toluene concentration and O2 concentration on toluene degradation using 0.1 wt%Au/γ-Al2O3 were evaluated. It showed the best catalytic performance of near 100% conversion for toluene degradation under the reaction conditions of the energy density was 20 J/L, the gas flow rate was 300 mL/min, the concentration of toluene was 376 mg/m3 and the oxygen content was 10%. Combining experimental results and theoretical calculations, the values of reaction constant k were 8.6 × 10-5, 3.53 × 10-5 and 3.09 × 10-5 m6/(mol*J), when O2 concentration, power or flow rate changed, respectively. Therefore, O2 concentration has the greatest effect on toluene decomposition compared to other factors in the presence of Au/γ-Al2O3.

Plasma-catalyst hybrid reactor with CeO2/γ-Al2O3 for benzene decomposition with synergetic effect and nano particle by-product reduction.

A dielectric barrier discharge (DBD) catalyst hybrid reactor with CeO2/γ-Al2O3 catalyst balls was investigated for benzene decomposition at atmospheric pressure and 30 °C. At an energy density of 37-40 J/L, benzene decomposition was as high as 92.5% when using the hybrid reactor with 5.0wt%CeO2/γ-Al2O3; while it was 10%-20% when using a normal DBD reactor without a catalyst. Benzene decomposition using the hybrid reactor was almost the same as that using an O3 catalyst reactor with the same CeO2/γ-Al2O3 catalyst, indicating that O3 plays a key role in the benzene decomposition. Fourier transform infrared spectroscopy analysis showed that O3 adsorption on CeO2/γ-Al2O3 promotes the production of adsorbed O2- and O22‒, which contribute benzene decomposition over heterogeneous catalysts. Nano particles as by-products (phenol and 1,4-benzoquinone) from benzene decomposition can be significantly reduced using the CeO2/γ-Al2O3 catalyst. H2O inhibits benzene decomposition; however, it improves CO2 selectivity. The deactivated CeO2/γ-Al2O3 catalyst can be regenerated by performing discharges at 100 °C and 192-204 J/L. The decomposition mechanism of benzene over CeO2/γ-Al2O3 catalyst was proposed.